Soy isoflavones

Phytoestrogen with meta-analysis support for a modest reduction in menopausal hot flush frequency and severity, with variable results.

Evidence
Moderate evidenceGRADE certainty: Moderate
Typical dose
≥54 mg/day genistein-equivalents from standardised extract for hot flush effect
Time to effect
Vasomotor effect emerges over 8–12 weeks
Safety
Has documented cautions

Evidence ratings summarise published research on Soy isoflavones in general. They are not a health claim for any product and not advice for any individual. Talk to your doctor before starting anything new, especially if you take medication.

Ask about Soy isoflavones

Interactions

Taking any medication?

Check Soy isoflavones against it.

Why

Soy isoflavones (genistein, daidzein, glycitein) have been studied for menopausal vasomotor symptoms for two decades. The Taku 2012 Menopause meta-analysis (17 RCTs, median 54 mg/day for 6 weeks to 12 months) reported a 20.6% reduction in hot flush frequency and a 26.2% reduction in severity versus placebo, with high heterogeneity between trials. NICE acknowledges some evidence but makes no recommendation, citing variable products and uncertain safety.

How it works

Isoflavones bind preferentially to oestrogen receptor β (vs α), producing tissue-selective oestrogenic effects, SERM-like. Equol (a gut bacterial metabolite of daidzein) has stronger ER-β affinity than the parent isoflavone.

Expected onset · Vasomotor effect emerges over 8–12 weeks

How to take

Dosage

≥54 mg/day genistein-equivalents from standardised extract for hot flush effect. Dietary intake from soy foods provides ~25–50 mg/day in soy-consuming populations.

Timing

Once daily with food

On the label

Standardised genistein and daidzein content per serving. Fermented soy (natto, miso, tempeh) and red clover (separate card) are alternative isoflavone sources.

Studied in

Postmenopausal women with troublesome vasomotor symptoms seeking a phytoestrogen approach.

Safety

Avoid in oestrogen-sensitive malignancy (breast, endometrial, ovarian), phytoestrogen activity is real, even though epidemiology in soy-consuming populations is reassuring. Caution with tamoxifen and aromatase inhibitors. Possible interaction with thyroid medication absorption. Separate by 2 hours. Pregnancy and breastfeeding: dietary soy is not a documented concern; supplement doses should be avoided.
Loading interactions…

Evidence

At a glance

Taku 2012 Menopause meta-analysis (17 RCTs, median 54 mg/day for 6 weeks to 12 months): soy isoflavone supplements lowered hot flash frequency by about 21% and severity by about 26% versus placebo in perimenopausal and postmenopausal women, with high heterogeneity between trials. The NICE menopause guideline (NG23) notes some evidence but cites variable products and uncertain safety.

GRADE certainty: Moderate — rated by Healicus using the GRADE method

Questions people ask

Does Soy isoflavones work?

Taku 2012 Menopause meta-analysis (17 RCTs, median 54 mg/day for 6 weeks to 12 months): soy isoflavone supplements lowered hot flash frequency by about 21% and severity by about 26% versus placebo in perimenopausal and postmenopausal women, with high heterogeneity between trials. The NICE menopause guideline (NG23) notes some evidence but cites variable products and uncertain safety. Certainty of the evidence: Moderate, rated by Healicus using the GRADE method.

How is Soy isoflavones taken?

≥54 mg/day genistein-equivalents from standardised extract for hot flush effect. Dietary intake from soy foods provides ~25–50 mg/day in soy-consuming populations. Timing: Once daily with food. Ranges are those reported in the cited sources, not individual advice; talk to your doctor or pharmacist before starting, especially if you take medication.

Are there interactions or cautions?

Avoid in oestrogen-sensitive malignancy (breast, endometrial, ovarian), phytoestrogen activity is real, even though epidemiology in soy-consuming populations is reassuring. Caution with tamoxifen and aromatase inhibitors. Possible interaction with thyroid medication absorption. Separate by 2 hours. Pregnancy and breastfeeding: dietary soy is not a documented concern; supplement doses should be avoided. Documented drug and supplement interactions can be looked up in the free interaction reference.

What is the evidence based on?

Sources: Taku et al., Menopause 2012, extracted or synthesized soybean isoflavones reduce menopausal hot flash frequency and severity: systematic review and meta-analysis; Setchell KD, Cole SJ, Method of defining equol-producer status and its frequency among vegetarians, J Nutr 2006; NICE guideline: Menopause: identification and management (NG23).

One evidence finding a day, like this one: follow Healicus on Threads or Bluesky.